45 related articles for article (PubMed ID: 2033654)
1. Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type beta 1, beta 2, and beta 1.2.
Schluesener HJ
J Neurosci Res; 1991 Feb; 28(2):310-4. PubMed ID: 2033654
[TBL] [Abstract][Full Text] [Related]
2. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factors type beta inhibit multidrug transport in rat astrocyte cell lines.
Schluesener HJ
Autoimmunity; 1991; 9(3):269-75. PubMed ID: 1685677
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous multidrug transport in human glioma cells is regulated by transforming growth factors type beta.
Schluesener HJ; Meyermann R
Acta Neuropathol; 1991; 81(6):641-8. PubMed ID: 1679277
[TBL] [Abstract][Full Text] [Related]
5. DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux.
Minderman H; Vanhoefer U; Toth K; Yin MB; Minderman MD; Wrzosek C; Slovak ML; Rustum YM
Cytometry; 1996 Sep; 25(1):14-20. PubMed ID: 8875050
[TBL] [Abstract][Full Text] [Related]
6. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
Li Y; Chen N; Yu HJ; Dong XP; Huang QH
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta, osteogenin, and bone morphogenetic protein-2 inhibit intercellular communication and alter cell proliferation in MC3T3-E1 cells.
Rudkin GH; Yamaguchi DT; Ishida K; Peterson WJ; Bahadosingh F; Thye D; Miller TA
J Cell Physiol; 1996 Aug; 168(2):433-41. PubMed ID: 8707879
[TBL] [Abstract][Full Text] [Related]
8. Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells.
McCaig C; Fowler CA; Laurence NJ; Lai T; Savage PB; Holly JM; Perks CM
Br J Cancer; 2002 Jun; 86(12):1963-9. PubMed ID: 12085194
[TBL] [Abstract][Full Text] [Related]
9. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
10. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the expression of the type-II collagen gene in periosteum-derived cells by three members of the transforming growth factor-beta superfamily.
Ballock RT; Heydemann A; Izumi T; Reddi AH
J Orthop Res; 1997 May; 15(3):463-7. PubMed ID: 9246095
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta receptor family ligands inhibit hepatocyte growth factor synthesis and secretion from astrocytoma cells.
Chattopadhyay N; T-Felt Hansen J; Godbole MM; Brown EM
Brain Res Mol Brain Res; 2004 Feb; 121(1-2):146-50. PubMed ID: 14969747
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
Andrews PW; Damjanov I; Berends J; Kumpf S; Zappavigna V; Mavilio F; Sampath K
Lab Invest; 1994 Aug; 71(2):243-51. PubMed ID: 7521445
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells.
Ro TB; Holt RU; Brenne AT; Hjorth-Hansen H; Waage A; Hjertner O; Sundan A; Borset M
Oncogene; 2004 Apr; 23(17):3024-32. PubMed ID: 14691444
[TBL] [Abstract][Full Text] [Related]
15. Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells?
Denis-Gay M; Petit JM; Ratinaud MH
Anticancer Res; 1995; 15(1):121-6. PubMed ID: 7733620
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-6 is expressed in nonparenchymal liver cells and upregulated by transforming growth factor-beta 1.
Knittel T; Fellmer P; Müller L; Ramadori G
Exp Cell Res; 1997 May; 232(2):263-9. PubMed ID: 9168801
[TBL] [Abstract][Full Text] [Related]
17. [Value of rhodamine 123 in the detection of minor amounts of multidrug resistant cells].
Maynadié M; Lizard G; Solary E; Parmeland C; Carli PM
Bull Cancer; 1994 May; 81(5):409-13. PubMed ID: 7749218
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein-2 suppresses invasiveness of TSU-Pr1 cells with the inhibition of MMP-9 secretion.
Kumagai T; Shimizu T; Takeda K
Anticancer Res; 2006; 26(1A):293-8. PubMed ID: 16475709
[TBL] [Abstract][Full Text] [Related]
19. Alteration of gene expression in response to bone morphogenetic protein-2 in androgen-dependent human prostate cancer LNCaP cells.
Kumagai T; Tomari K; Shimizu T; Takeda K
Int J Mol Med; 2006 Feb; 17(2):285-91. PubMed ID: 16391828
[TBL] [Abstract][Full Text] [Related]
20. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
